Fagopyrum tataricum (Buckwheat) Improved High-Glucose-Induced Insulin Resistance in Mouse Hepatocytes and Diabetes in Fructose-Rich Diet-Induced Mice by Lee, Chia-Chen et al.
Hindawi Publishing Corporation
Experimental Diabetes Research
Volume 2012, Article ID 375673, 10 pages
doi:10.1155/2012/375673
Research Article
Fagopyrumtataricum (Buckwheat) Improved
High-Glucose-InducedInsulinResistanceinMouseHepatocytes
andDiabetes inFructose-RichDiet-InducedMice
Chia-ChenLee, Wei-HsuanHsu, Siou-RuShen, Yu-HsiangCheng, andShe-Ching Wu
Department of Food Science, National Chiayi University, Chiayi City 60004, Taiwan
Correspondence should be addressed to She-Ching Wu, scwu@mail.ncyu.edu.tw
Received 9 October 2011; Accepted 11 January 2012
Academic Editor: Pietro Galassetti
Copyright © 2012 Chia-Chen Lee et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Fagopyrum tataricum (buckwheat) is used for the treatment of type 2 diabetes mellitus in Taiwan. This study was to evaluate
the antihyperglycemic and anti-insulin resistance eﬀects of 75% ethanol extracts of buckwheat (EEB) in FL83B hepatocytes by
high-glucose (33mM) induction and in C57BL/6 mice by fructose-rich diet (FRD; 60%) induction. The active compounds of
EEB (100μg/mL; 50mg/kgbw), quercetin (6μg/mL; 3mg/kgbw), and rutin (23μg/mL; 11.5mg/kgbw) were also employed to
treat FL83B hepatocytes and animal. Results indicated that EEB, rutin, and quercetin + rutin signiﬁcantly improved 2-NBDG
uptake via promoting Akt phosphorylation and preventing PPARγ degradation caused by high-glucose induction for 48h in
FL83B hepatocytes. We also found that EEB could elevate hepatic antioxidant enzymes activities to attenuate insulin resistance as
well as its antioxidation caused by rutin and quercetin. Finally, EEB also inhibited increases in blood glucose and insulin levels of
C57BL/6 mice induced by FRD.
1.Introduction
Type 2 diabetes mellitus (T2DM) is a chronic disease caused
by deﬁcient insulin secretion or ineﬀective insulin activity,
whichnegativelyaﬀectscarbohydratemetabolism.Medicinal
plantsareusedasacommonalternativetreatmentforT2DM
in many parts of the world. Insulin resistance is associated
with inﬂammatory factors such as tumor necrosis factor-α
(TNF-α)andinterleukin-6(IL-6)inT2DMpatients.Cellular
stress due to obesity is thought to be associated with the
disturbance of homeostasis in the endoplasmic reticulum
(ER). Hepatic regulation of glucose homeostasis is the major
factor controlling plasma glucose concentrations, and the
induction of hepatic ER stress and oxidative stress resulting
in insulin resistance has been investigated [1].
High-fructose diet upregulates hepatic expression of the
sterol regulatory element binding protein-1c (SREBP-1c), a
key transcription factor for hepatic expression of lipogenic
enzymes, but down regulates the expression of PPARα (pro-
moting fatty acid oxidation) [2, 3]. The study also
investigatesthefructose-inducingeﬀectinC57BL/6miceand
has found that fructose would promote SREBP-1c promoter
activity resulting in hepatic lipogenesis [4]. Moreover, fruc-
tose is employed to induce insulin resistance, hepatic stea-
tosis, and the metabolic syndrome [5]. Fructose is a highly
lipogenic sugar that has profound metabolic eﬀects in the
liver resulting in metabolic syndrome, and fructose does not
stimulate insulin secretion [6] .T h er a t eo fh e p a t i cu p t a k e
of fructose from portal circulation is greater than the rate of
glucose uptake, and because fructose metabolism bypasses
phosphofructokinase, fructose metabolism is not under the
regulatory control of insulin [7]. On the other hand, fructose
may activate SREBP-1c which activates genes involved in de
novo lipogenesis, and triglyceride [8].
Fagopyrum tataricum (buckwheat) is a herbaceous plant
that belongs to the Polygonaceae family. It has now been in-
troduced in many countries, because the seeds of this herb
are a healthy and nutritionally important food item. Rutin
has been found to be the major ingredient of buckwheat [9].
Tartary buckwheat (F. tataricum) contains more rutin and
quercetin than common buckwheat (F. esculentum)d o s e ;
rutin is known to have antioxidative activity [10]. Due to2 Experimental Diabetes Research
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Figure 1:(a)TheHPLCchromatogramofstandards(rutinandquercetin):(1)caﬃcacid,(2)rutin,(3)quercetin-3-glucoside,(4)quercetin,
and (5) kaempferol. (b) The HPLC chromatogram of sample (75% ethanol extracts of F. tataricum).
the rise in recent years to investigate the anti-diabetic activity
of antioxidants, anti-insulin resistance of rutin, quercetin,
and the 75% ethanol extracts from buckwheat (EEB) in vivo
and in vitro were investigated in this study.
2.MaterialsandMethods
2.1. Materials and Chemicals. 3-(4,5-Dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT), glucose, querce-
tin, Triton-X 100, rutin, and trypsin were purchased from
Sigma Co. (St. Louis, MO, USA). Sodium bicarbonate, fetal
bovine serum (FBS), F12-K medium, penicillin, and strepto-
mycin were purchased from HyClone Laboratories (Logan,
UT, USA). The Bio-Rad protein assay dye was from Bio-Rad
Laboratories (Hercules, CA, USA). 2-[N-(7-Nitrobenz-2-
oxa-1,3-diazol-4-yl)amino]-2-deoxy-d-glucose (2-NBDG)
was from Invitrogen (Carlsbad, CA, USA).
2.2. Preparation of Sample. The seeds of F. tataricum (buck-
wheat) were provided by Taiwan Golden Buckwheat Limited
company) and then were freeze-dried and ground. Approx-
imately 2.5kg of the buckwheat powder was extracted by
25L of 75% ethanol for 2 days. After extraction, the ethanol
extracts were vacuum-concentrated and freeze-dried. The
extractpowderwasstoredat −20◦Cuntilused.The75%eth-
anol extracts of buckwheat was shown as EEB in this study.
2.3. Cell Culture. FL83B cells were seeded in 10cm dishes
at a density of 5 × 105 per well and grown until 80% con-
ﬂuence was reached. Subsequently, insulin resistance was in-
duced in these cells and glucose uptake was determined [11].
FL83B cell line is a mouse normal liver cell from the Biore-
source Collection and Research Center (BCRC) in Taiwan
(Hsinchu, Taiwan), which is cultured in the F12-K medium
supplemented with 10% heat-inactivated FBS and antibi-
otics (100unit/mL penicillin and 100μg/mL streptomycin).
C e l l sw e r ec u l t u r e da t3 7 ◦C in a humidiﬁed atmosphere of
5% CO2.
2.4. High-Performance Liquid Chromatography (HPLC)
Assay. HPLC was performed with a Hitachi liquid chro-
matograph (Hitachi, Ltd., Tokyo, Japan) consisting of a
model L-6200 pump and a model L-4200 UV-Vis detec-
tor set at 320nm. The analyses were carried out on a
LiChrospher RP-18 column (250mm·4.6mm i.d., 5μm, E.
Merck Co., Darmstadt, Germany). Extracts were ﬁltered
through a 0.45μm ﬁlter before use. The mobile phase A
was 2% acetic acid, and the mobile phase B was 0.5% acetic
acid/water (1:1; v/v). Caﬃc acid, rutin, quercetin, kaemp-
ferol, and quercetin-3-glucoside were determined by ultra-
violet detector (Hitachi L-7455 diode array detector). Caﬃc
acid,rutin,quercetin,kaempferol,andquercetin-3-glucoside
were identiﬁed by comparison of their retention time (Rt)
values and UV spectra with those of known standards and
determined by peak areas from the chromatograms [12].
Results suggested that 228.8mg/g of rutin and 58.6mg/g of
quercetin were contained in EEB (Figure 1).
2.5. Cell Viability. Mouse FL83B cells (1.5 × 105 cells per
well) were seeded into 24-well plates overnight. Cells were
treated with high glucose (33mM) and sample (quercetin/
rutin/EEB) in free-serum F12-K medium for 48h. Subse-
quently, cells were washed with phosphate buﬀered saline
(PBS) twice, and the supernatants were exchanged with 1mL
of medium and MTT (0.5mg/mL) to react for 2h at 37◦C.
After reaction, removing medium, and washing cells with
PBS, the MTT reacted product (formazan crystals) was dis-
solved with 0.5mL of dimethyl sulfoxide (DMSO), and the
absorption was measured at 570nm by an ELISA reader for
cell viability assay.
2.6. Insulin Resistance Induction and Glucose (2-NBDG) Up-
take. Glucose uptake of FL83B cells was assessed using the
ﬂuorescent glucose analog, 2-NBDG. Brieﬂy, cells were treat-
ed with high glucose (33mM) and sample in serum-free
medium for 48 hours, and then the medium was replaced
with Krebs-Ringer-Bicarbonate (KRB) buﬀer containing
insulin(500nM;ﬁnalconcentration)and2-NBDG(160μM;
ﬁnal concentration) for 20min for incubation at 37◦C. Free
2-NBDG was washed out from cultures after treatment and
measured 2-NBDG with a FACS ﬂow cytometer (BD Bio-
sciences, San Jose, CA, USA) and analyzed using CellQuest
software [11].
2.7. Western Blot Analysis. FL83B cells were lysed in ice-cold
lysis buﬀer containing 20mM of Tris-HCl (pH 7.4), 1% of
Triton X-100, 0.1% of SDS, 2mM of EDTA, 10mM of NaF,
1mM of phenylmethylsulfonyl ﬂuoride (PMSF), 500μMo f
sodium vanadate, and 10μg/mL of aprotinin overnight. And
then the cell lysates were sonicated with ice cooling (fourExperimental Diabetes Research 3
times each 15s) and then centrifuged (12,000×g, 10min) to
recover the supernatant. The supernatant was taken as the
cell extract. The protein concentration in the cell extract was
determined using a Bio-Rad protein assay kit. The samples
were subjected to 10% sodium dodecyl sulfate-polyacrylam-
ide gel electrophoresis (SDS-PAGE). The protein spots were
electrotransferred to a polyvinylidene diﬂuoride (PVDF)
membrane. The membrane was incubated with block buﬀer
(PBS containing 0.05% of Tween-20 and 5% w/v nonfat dry
milk) for 1h, washed with PBS containing 0.05% Tween-20
(PBST)threetimes,andthenprobedwithanti-Aktantibody,
anti-PTP1B, anti-GS, anti-p-PKC, anti-PKC, anti-AMPK,
anti-p-Akt, anti-GLUT2, and anti-PPAR-γ antibodies (Cell
Signaling Technology, Beverly, MA, USA) overnight at 4◦C.
In addition, the intensity of the blots probed with 1:1000
diluted solution of mouse monoclonal antibody to bind
GAPDH (Cell Signaling Technology) was used as the control
to ensure that a constant amount of protein was loaded into
each lane of the gel. The membrane was washed three times
each for 5min in PBST, shaken in a solution of HRP-linked
anti-rabbit IgG secondary antibody, and washed three more
times each for 5min in PBST. The expressions of proteins
were detected by enhanced chemiluminescent (ECL) reagent
(Millipore, Billerica, MA, USA).
2.8. Animals Study. C57BL6 mice (4 weeks old) were ob-
tained from BioLASCO, Taiwan Co., Ltd. in this study. Ani-
mals were provided with food and water ad libitum. Animals
were subjected to 12h light/dark cycle with a maintained rel-
ativehumidityof60%andatemperatureat25◦C.Theexper-
iments were carried out in a qualiﬁed animal breeding room
in the animal center at our institute. Hyperglycemia and
hyperinsulinemia in mice were induced by fructose-rich diet
(FRD; 60%) for 8 weeks of induction [13] .T h ea n i m a l sw e r e
randomly divided into 6 groups (n = 12), including (a) con-
trol,(b)fructose-richdiet(FRD),(c)FRD+quercetin(3mg/
kgbw), (d) FRD + rutin (11.5mg/kgbw), (e) FRD + EEB
(50mg/kgbw), and (f) FRD + rutin + quercetin. The doses
of rutin and quercetin were equivalent to those administered
to the EEB administration group.
2.9. Oral Glucose Tolerance Test (OGTT). The OGTT was
performed at week 4 and week 8. The experiment was per-
formedonanimalsafterfastingfor12h(freeaccesstowater).
Animals were given glucose (2g/kg of body weight) with
an oral administration. Blood samples were collected from
the tail vein at times 0, 30, 60, 90, and 120min after glu-
cose administration. Homeostasis model assessment of in-
sulin resistance (HOMA-IR) was calculated according to the
formula HOMA-IR = fasting insulin × fasting blood glu-
cose/22.5 [14, 15].
2.10. Assays for Blood Glucose. Blood glucose was immedi-
ately determined by the glucose oxidase method, using an
analyzer [16].
2.11. Assay for Antioxidase Activity. Glutathione peroxidase
(GPx) activity was determined as previously described
[17]. Glutathione reductase (GR) activity determination was
according to Bellomo et al. (1987) [18]. The catalase (CAT)
activity was determined by the method of Aebi (1984) [19].
SOD activity was determined by the method of S. Marklund
and G. Marklund (1974) [20].
2.12. Assay for Hepatic and Pancreatic Reactive Oxygen Species
(ROS). The ROS levels were assayed with nitroblue tetra-
zolium (NBT), which is reduced to form blue-black forma-
zan.Inthisassay,100μLofhomogenat esr eact edwith10mg/
mL of NBT and measured by the absorbance at 570nm [21].
2.13. Assay for Insulin Level. Insulin was determined by the
insulin kit derived from Mercodia AB (Uppsala, Sweden).
2.14. Histopathologic Studies. Liver tissues were trimmed
(2mm thickness) and ﬁxed (buﬀer formaldehyde). The ﬁxed
tissues were processed including those embedded in paraﬃn,
sectioned, and rehydrated. The histological examination by
the previous conventional methods evaluated the index of
ethanol-induced necrosis by assessing the morphological
changes in the liver sections stained with hematoxylin and
eosin (H and E) [22].
2.15. Statistical Analysis. Experimental results were averaged
triplicate analysis. The data were recorded as mean ± stand-
ard deviation (SD) and analysis by statistical analysis system
(SAS Inc., Cary, NC, USA). One-way analysis of variance was
performed by ANOVA procedures. Signiﬁcant diﬀerences
between means were determined by Duncan’s multiple range
tests. Results were considered statistically signiﬁcant at P<
0.05.
3. Results and Discussion
3.1. Eﬀects of EEB, Rutin, and Quercetin on High-Glucose-
Induced Insulin Resistance in the FL83B Hepatocytes for 48h.
Caﬃc acid, rutin, quercetin, kaempferol, and quercetin-3-
glucoside of EEB were identiﬁed by HPLC. Results sug-
gested that 228.8mg/g of rutin and 58.6mg/g of quercetin
were contained in EEB (Figure 1). We performed a 2-
NBDG uptake test involving FL83B cells with high-glucose
(33mM)-induced insulin resistance to evaluate the eﬀects of
EEB (100μg/mL), rutin (23μg/mL; 37μM), and quercetin
(6μg/mL; 20μM) on improving insulin sensitivity. The re-
sults showed that EEB, quercetin, and rutin signiﬁcantly in-
creased glucose uptake in these cells (Figure 2(a)). Further-
more, the treating concentrations of EEB, rutin, and querce-
tin without cytotoxic eﬀects were found in FL83B hepato-
cytes (data not shown).
Akt is a Ser/Thr protein kinase that plays a key role
in the translocation of glucose transporter (GLUT) to
the plasma membrane via a signal transduction cascade
involving insulin treatment [23]. We determined whether
activatedAktwasinvolvedintheanti-insulinresistanceeﬀect
of EEB, rutin, quercetin, and rutin + quercetin on glucose
uptake. The treatment of high glucose signiﬁcantly inhibited
Akt phosphorylation in FL83B hepatocytes (Figure 2(b)).
These results showed that exposure to high concentrations of
glucose induces an insulin resistance-like condition includ-
ing inhibition of the Akt pathway and EEB, rutin, quercetin,4 Experimental Diabetes Research
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Figure 2: Eﬀects of EEB on 2-NBDG uptake (a), Akt phosphorylation (b), and GLUT2 expression (c) of FL83B hepatocytes induced by high
glucose. FL83B cells were incubated in serum-free F12K medium with glucose (33mM; ﬁnal concentration) with or without EEB, quercetin,
rutin, and quercetin + rutin for 48h. EEB: 75% ethanol extracts of buckwheat. #Signiﬁcantly diﬀerent (P<0.05) from normal; ∗signiﬁcantly
diﬀerent (P<0.05) from high-glucose treating group.
and rutin + quercetin could overcome the insulin resistance
by activating the Akt pathways, thus resulting in increased
glucose uptake.
GLUT2 is the major glucose transporter expressed in
hepatocytes, insulin-secreting pancreatic β-cells and absorp-
tive epithelial cells of the intestinal mucosa and kidney.
GLUT2 is thought to act as a glucose-sensing apparatus that
plays a role in blood glucose homeostasis, by responding
to changes in blood glucose concentration and altering
the rate of glucose uptake by hepatocytes. High-glucose
levels decreased GLUT2 protein expression in FL83B cells,
but EEB, rutin, quercetin, and rutin + quercetin markedly
increased GLUT2 protein expression (Figure 2(c)). Results
showed that EEB, rutin, and quercetin promoted Akt
phosphorylation, in turn promoting GLUT2 translocation
into plasma membrane of FL83B cells thereby increasing
glucose uptake and alleviating insulin resistance induced by
high-glucose. Although rutin + quercetin treatment did not
show the synthetic eﬀect on 2-NBDG uptake, Akt phospho-
rylation, and GLUT2 expression in high-glucose-induced
FL83B hepatocytes compared to quercetin- or rutin-treated
groups.
3.2. Eﬀects of EEB, Rutin, and Quercetin on AMP-Dependent
Protein Kinase (AMPK), Protein Tyrosine Phosphatase 1B
(PTP1B), and Glycogen Synthase (GS) Expressions in FL83B
Hepatocytes. AMPK is a conserved intracellular energy sen-
sor that plays a central role in the regulation of glucose and
lipid metabolism, and AMPK has multiple biological eﬀects,
including the regulation of intracellular glucose transport
[24]. Recent investigations suggest that AMPK could poten-
tially be beneﬁcial as a therapeutic target in the treatment of
diabetesandobesity[25].However,AMPKexpressionwould
beinhibitedbyoxidativestressandERstressininﬂammatory
factors or high-glucose induction downregulating AMPK
expression and phosphorylation [1, 5, 6, 8]. On the other
hand, hepatic speciﬁc PTP1B plays a pivotal role in glucose
and lipid metabolism. Inhibition of PTP1B in the peripheral
tissues may be beneﬁcial with respect to the treatment of
diabetes as well as the treatment of metabolic syndrome andExperimental Diabetes Research 5
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Figure 3: Eﬀects of EEB on AMPK (a), PTP1B (b), and GS expressions (c) of FL83B hepatocytes induced by high glucose. FL83B cells were
incubated in serum-free F12K medium with glucose (33mM; ﬁnal concentration) with or without EEB, quercetin, rutin, and quercetin+
rutin for 48h. EEB: 75% ethanol extracts of buckwheat. #Signiﬁcantly diﬀerent (P<0.05) from normal; ∗signiﬁcantly diﬀerent (P<0.05)
from high-glucose-treated group.
reduction of cardiovascular risk. Study has demonstrated
that PTP1B expression involved in ER stress in high-glu-
cose induction [1, 24]. In addition, the natural product,
monascin,identiﬁedfromMonascus-fermentedproductshas
beendemonstratedtoshowtheinhibitoryactivityforPTP1B
expression in insulin-resistance-induced C2C12 cells [26].
We evaluated the eﬀects of EEB, rutin, and quercetin
on AMPK and PTP1B expression of FL83B hepatocytes in-
duced by high-glucose treatment for 48h. Results indicated
that EEB, rutin, and quercetin signiﬁcantly prevented a de-
crease in AMPK (Figure 3(a)), and the inhibition of PTP1B
was found in EEB, rutin, and quercetin treatments in high-
glucose-induced FL83B hepatocytes (Figure 3(b)). These re-
sults showed that EEB, rutin, and quercetin could signiﬁ-
cantly regulate AMPK and PTP1B activity in FL83B hepa-
tocytes thereby attenuating insulin resistance and promoting
2-NBDG uptake.
Moreover, we investigated the GS expression of FL83B
hepatocytes induced by high-glucose treatment for 48h.
Results indicated that EEB, rutin, and rutin + quercetin
could promote GS expression compared to the high-glucose-
induced group; however, this eﬀect was not found in the
quercetin-treated group (Figure 3(c)).
3.3. Antioxidative Stress and Anti-PPARγ Phosphorylation
b yE E B ,R u t i n ,a n dQ u e r c e t i ni nF L 8 3 BH e p a t o c y t e s .High-
glucose levels have been shown to induce the activities of
inﬂammatorycytokines,chemokines,p38mitogen-activated
protein kinase, reactive oxygen species (ROS), protein kinase
C (PKC), and nuclear factor-κB( N F - κB) activity in clinical
and experimental systems [27–29]. We evaluated the inhi-
bitory eﬀect of EEB on ROS production in this study.
High-glucose levels signiﬁcantly increased ROS production,
whereas EEB, rutin, quercetin, and rutin + quercetin treat-
ments could decrease ROS production in high-glucose-
induced FL83B hepatocytes (Figure 4). Activation of p-PKC
directly contributes to the oxidative stress and membrane-
associated NADPH oxidases, which further leads to exces-
sive ROS production. Results suggested that EEB, rutin,
quercetin, and rutin + quercetin markedly inhibited PKC6 Experimental Diabetes Research
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Figure 5: Eﬀects of EEB on PKC phosphorylation (a) and PPARγ expressions (b) of FL83B hepatocytes induced by high glucose. FL83B cells
were incubated in serum-free F12K medium with glucose (33mM; ﬁnal concentration) with or without EEB, quercetin, rutin, and quercetin
+ rutin for 48h. EEB: 75% ethanol extracts of buckwheat. #Signiﬁcantly diﬀerent (P<0.05) from normal; ∗signiﬁcantly diﬀerent (P<0.05)
from high-glucose-treated group.
phosphorylation caused by high-glucose induction for 48h
(Figure 5(a)).
Peroxisomeproliferator-activatedreceptors (PPARs)reg-
ulate cellular development and diﬀerentiation and govern
cellularbioenergeticsbymodulatingfatandglucosemetabo-
lism and inﬂammatory responses [30]. There are three PPAR
subtypes, including PPAR-α,P P A R - γ, and PPAR-δ. All three
subtypes can modulate DNA transcription by binding to
speciﬁc peroxisome-proliferator-response elements (PPREs)
on target genes. Moreover, PPAR-γ plays an important role
in the development of insulin resistance. PPARγ plays a key
role in adipogenesis, survival of mature adipocytes, fatty
acid uptake, lipid storage, and systemic energy homeostasis.
The metabolic regulation of PPAR-γ for glucose homeostasis
is investigated in the study [31]. High-glucose induction
attenuating insulin sensitivity has been found via activat-
ing PKC [26]. PKC inhibits PPAR-γ function via direct
phosphorylation at serine residues, aﬀecting DNA-binding
activityandincreasingPPAR-γ degradationbytheubiquitin-
proteasome-dependent pathway [26, 31].
Therefore, we postulated that the EEB, rutin, quercetin,
and rutin + quercetin could prevent a decrease in PPAR-γ of
high-glucose-induced FL83B hepatocytes; this result may at-
tribute to EEB, rutin, quercetin, and rutin + quercetin signi-
ﬁcantly inhibiting p-PKC activation thereby attenuating
PPARγ phosphorylation and degradation (Figure 5(b)).
3.4. The Regulation of EEB, Rutin, Quercetin, and Rutin +
Quercetin on Blood Glucose In Vivo . Fructose is employed to
induceinsulinresistance,hepaticsteatosis,andthemetabolic
syndrome [32]. Fructose is a highly lipogenic sugar that has
profound metabolic eﬀects in the liver resulting in metabolic
syndrome, and fructose does not stimulate insulin secretion
[6]. The rate of hepatic uptake of fructose from portalExperimental Diabetes Research 7
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Figure 6: The regulatory eﬀect of EEB, quercetin, rutin, and quercetin + rutin on OGTT in C57BL/6 mice induced by fructose-rich diet
(FRD; 60%) for 8 weeks. The animals were randomly divided into 6 groups (n = 12), including (a) control, (b) fructose-rich diet (FRD), (c)
FRD+quercetin(3mg/kgbw),(d)FRD+rutin(11.5mg/kgbw),(e)FRD+EEB(50mg/kgbw),and(f)FRD+rutin+quercetin.Thedoses
of rutin and quercetin were equivalent to those administered to the EEB administration group. EEB: 75% ethanol extracts of buckwheat.
Data are presented as the mean ± SEM. #Signiﬁcantly diﬀerent (P<0.05) from control group.
Table 1: Eﬀects of EEB on HOMA-IR by levels of blood glucose and insulin in FRD-induced rats.
Groups
Week 8
Glucose (mmol/L) Insulin (mIU/L) HOMA-IR
Normal 6.4 ±0.41 0 .3 ±0.42 .9 ±0.4
HFD 7.8 ±0.0# 18.1 ±0.5# 6.3 ±0.7#
HFD + quercetin 7.5 ±0.1# 17.1 ±0.7# 5.7 ±0.2#
HFD + rutin 7.2 ±0.1#∗ 15.3 ±0.4#∗ 4.9 ±0.4#∗
HFD + EEB 6.9 ±0.4#∗ 11.2 ±0.3
∗ 3.4 ±0.8#∗
HFD + quercetin + rutin 7.0 ±0.3#∗ 13.6 ±0.2
∗ 4.2±0.1#∗
Hyperglycemia and hyperinsulinemia in mice were induced by fructose-rich diet (FRD; 60%) for 8 weeks. The animals were randomly divided into 6
groups (n = 12), including (a) control, (b) fructose-rich diet (FRD), (c) FRD + quercetin (3mg/kgbw), (d) FRD + rutin (11.5mg/kgbw), (e) FRD + EEB
(50mg/kgbw), and (f) FRD + rutin + quercetin. The doses of rutin and quercetin were equivalent to those administered to the EEB administration group.
Data are presented as the mean ± SEM. #Signiﬁcant diﬀerence from the control group (P<0.05). ∗Signiﬁcant diﬀerence form the FRD group (P<0.05).
The statistics were shown by the t-test.
circulation is greater than the rate of glucose uptake, and
because fructose metabolism bypasses phosphofructokinase,
fructose metabolism is not under the regulatory control of
insulin [7].
The levels of blood glucose and insulin in the FRD-
induced group were signiﬁcantly increased compared with
thenormalgroup,suggestingthattheFRDmarkedlyinduced
hyperinsulinemia and hyperglycemia, and the elevations of
blood glucose and insulin both were inhibited by EEB and
rutin/quercetin + rutin treatments; moreover, the HOMA-
IR value by FRD induction was signiﬁcantly reduced by EEB
and rutin/quercetin + rutin treatments (Table 1). On the
other hand, the improvement of EEB and rutin/quercetin
+ rutin administrations for regulating blood glucose in
OGTT test was signiﬁcantly observed compared to the con-
trol group and FRD-induced group, suggesting that the hy-
poglycemic activity of rutin + quercetin and EEB are both
greater than rutin or quercetin administration from 30min
to 120min (Figure 6). However, these eﬀects were not found
in quercetin administration group, indicating that EEB and
which active compound (rutin) both improved insulin sen-
sitivity in C57BL/6 mice induced by FRD.
3.5. The Improvements of EEB, Rutin, Quercetin, and Rutin+
Quercetin on Fatty Acid/Cholesterol Generation and Accumu-
lation. Plasma and hepatic fatty acid/cholesterol are com-
monly associated with impaired insulin-mediated glucose
uptake in related tissues and coexist with type 2 diabetes
and obesity [33]. As shown in Table 2, EEB and rutin/quer-
cetin + rutin could improve plasma and hepatic TC,
TG, HDL-C, and LDL-C levels compared to the FRD-
inducedgroup,therebyshowingantihyperglycemicandanti-
hyperinsulinemic activities. In addition, FRD induction
for 8 weeks signiﬁcantly increased fatty degeneration and8 Experimental Diabetes Research
Table 2: Eﬀect of EEB on hepatic and serum TC, TG, HDL, and LDL levels in FRD-induced rats at week 8.
Groups Hepatic TG Hepatic TC Hepatic HDL-C Hepatic LDL-C
Concentration (mg/g)
Normal 298.2 ±3.62 6 .6 ±1.61 7 .9 ±0.2 373.4 ±1.2
FRD 385.2 ±7.1# 39.5 ±1.3# 17.7 ±0.8 457.2 ±3.9#
FRD + quercetin 359.8 ±4.2#∗ 38.9 ±2.6# 16.0 ±0.3 429.7 ±4.6#
FRD + rutin 322.2 ±7.4#∗ 29.6 ±1.9#∗ 17.1 ±0.4 393.1 ±3.4#∗
FRD + EEB 310.0 ±6.2
∗ 24.7 ±1.4
∗ 15.7 ±0.4
∗ 378.5 ± 2.0
∗
FRD + quercetin + rutin 317.9 ±7.3
∗ 27.9 ±1.1
∗ 16.7 ±0.1 359.8 ±10.1
∗
Groups Plasma TG Plasma TC Plasma HDL-C Plasma LDL-C
Concentration (mg/dL)
Normal 124.6±1.7 69.0 ±1.17 1 .8 ±2.5 126.5 ±1.5
FRD 238.0 ±1.1
∗ 94.3 ±3.1# 52.6 ±1.6# 239.5 ±4.7#
FRD + quercetin 193.5 ±6.6#∗ 89.0 ±5.3# 54.1 ±3.7# 235.5 ±5.6#
FRD + rutin 172.0 ±3.3#∗ 82.7 ±2.8#∗ 52.5 ±5.3# 211.4 ±1.6#∗
FRD + EEB 148.5 ±8.7#∗ 76.6 ±2.4#∗ 62.8 ± 2.2#∗ 187.5 ±3.9#∗
FRD + quercetin + rutin 138.2 ±6.4
∗ 80.5 ±2.4#∗ 59.4 ± 1.5#∗ 193.2 ±1.8#∗
Hyperglycemia and hyperinsulinmia in mice were induced by fructose-rich diet (FRD; 60%) for 8 weeks. The animals were randomly divided into 6
groups (n = 12), including (a) control, (b) fructose-rich diet (FRD), (c) FRD + quercetin (3mg/kgbw), (d) FRD + rutin (11.5mg/kgbw), (e) FRD + EEB
(50mg/kgbw), and (f) FRD + rutin + quercetin. The doses of rutin and quercetin were equivalent to those administered to the EEB administration group.
Data are presented as the mean ± SEM. #Signiﬁcant diﬀerence from the control group (P<0.05). ∗Signiﬁcant diﬀerence form the FRD group (P<0.05).
The statistics were shown by the t-test.
Table 3: Eﬀects of EEB on hepatic antioxidase activity in FRD-induced rats at week 8.
Groups
Hepatic antioxidant enzyme activity
CAT GR GPx SOD
nmol H2O2/min/mg
protein
nmol NADPH/min/mg protein U/mg protein
Normal 126.3 ± 1.6 5963 ±11 5438 ±32 65.8 ±0.7
FRD 90.4 ±3.0# 4543 ±56# 4019 ±57# 50.3 ± 0.6#
FRD + quercetin 120.8 ±1.8
∗ 4326 ±52# 4089 ±34# 58.5 ± 1.9#∗
FRD + rutin 117.9 ±2.9
∗ 5107 ±60#∗ 4101 ±55# 65.0 ± 2.6
∗
FRD + EEB 127.1 ±3.7∗ 6211 ±58
∗ 4739 ±38#∗ 67.1 ± 1.4
∗
FRD + quercetin + rutin 121.0 ±2.0
∗ 5842 ±32
∗ 4997 ±22#∗ 62.2 ±1.7
∗
Hyperglycemia and hyperinsulinemia in mice were induced by fructose-rich diet (FRD; 60%) for 8 weeks. The animals were randomly divided into 6
groups (n = 12), including (a) control, (b) fructose-rich diet (FRD), (c) FRD + quercetin (3mg/kgbw), (d) FRD + rutin (11.5mg/kgbw), (e) FRD + EEB
(50mg/kgbw), and (f) FRD + rutin + quercetin. The doses of rutin and quercetin were equivalent to those administered to the EEB administration group.
Data are presented as the mean ± SEM. #Signiﬁcant diﬀerence from the control group (P<0.05). ∗Signiﬁcant diﬀerence form the FRD group (P<0.05).
The statistics were shown by the t-test.
accumulation provided histopathological evidence of liver
tissue;however,thesehistopathologicinjurieswereimproved
by EEB, rutin/quercetin + rutin administration (Figure 7).
3.6. Eﬀects of EEB on Hepatic Antioxidant Enzymes Activity.
Several lines of evidence have established that excessive oxi-
dative stress caused by reactive oxygen species (ROS) and
reactive nitrogen species (RNS) can promote disease pro-
gression through oxidation of biomolecules such as DNA,
lipids, and proteins [34, 35]. Oxidative stress contributes
to diabetes and other human diseases [36]. Elevated levels
of free fatty acid have been inhibiting insulin secretion
by mitochondrial oxidation in the establishment of insulin
resistance in diabetes mellitus [37]. An association between
oxidative stress and insulin resistance has been reported in
diabetes [38]. The results described above indicated that
FRD induction resulted in lipid accumulation in the liver,
resulting in insulin resistance. Therefore, the preventiveExperimental Diabetes Research 9
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Figure 7:TheeﬀectsofEEB,quercetin,rutin,andquercetin+rutinonfattyacidaccumulationinliverofC57BL/6miceinducedbyfructose-
rich diet (FRD; 60%) for 8 weeks. The animals were randomly divided into 6 groups (n = 12), including (a) control, (b) fructose-rich diet
(FRD),(c)FRD+quercetin(3mg/kgbw),(d)FRD+rutin(11.5mg/kgbw),(e)FRD+EEB(50mg/kgbw),and(f)FRD+rutin+quercetin.
EEB: 75% ethanol extracts of buckwheat. The doses of rutin and quercetin were equivalent to those administered to the EEB administration
group.
eﬀe c t so fE E Ba n dr u t i n / q u e r c e t i n+r u t i no no x i d a t i v es t r e s s
in the liver of FRD-induced mice were evaluated in this
study. The results suggested that EEB and rutin/quercetin +
rutin administration signiﬁcantly increased CAT, GR, GPx,
and SOD activities in liver of FRD-induced C57BL/6 mice
(Table 3).
4. Conclusion
In conclusion, we evaluated the eﬀects of EEB, rutin, and
quercetinontheinsulinresistancepathwayinFL83Bhepato-
cytes with high-glucose-level-induced insulin resistance. We
found that EEB, rutin, and quercetin may alleviate insulin
resistance by improving insulin signaling via p-PKC activity
inhibition and glucose uptake enhancement in insulin-re-
sistant cells. In addition, we proposed that alleviation of in-
sulin resistance was involved in the antioxidative eﬀect of
thesephenolicacidsinC57BL/6miceinducedbyFRD(60%)
for 8 weeks. We found that EEB and rutin/quercetin + rutin
could improve hyperglycemia and hyperinsulinemia but
quercetin administration did not show these activities, sug-
gesting that rutin was major active compound of EEB. Taken
together, the present study showed that EEB, rutin, and
quercetin exerted antihyperglycemic and antioxidant activi-
ties because of their multiple eﬀects, including antioxidative
capacity and promotion of antioxidation enzymes, for
protecting oxidative stress-induced insulin resistance in
FL83B hepatocytes.
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